CAPhO Compass

The Compass is the blog of the Canadian Association of Oncology in Pharmacy. It covers multiple topics related to the practice of oncology pharmacy in Canada. For information about how to submit a post, please contact the Communications Committee Chair

Guest post by Sarah Lutes, Pharmacy Resident, AHS Cancer Control

Currently, the standard practice at Alberta Health Services for newly diagnosed grade 3 and 4 glioma is surgery plus radiation. Patients with 1p/19q-codeleted tumors are also given six cycles of procarbazine, lomustine and vincristine (PCV). There is currently no accepted standard practice for recurrent glioblastoma mulitforme (GBM), however the RESCUE protocol (temazolamide 50mg/m2 given daily) or Avastin® (bevacizumab) are used most often. Other options include...Read more

by Amy Smith, as part of her Green Oncology series

The Issue:

During my “on-again, off-again” relationship with formal education, I have experienced experiential learning from both sides. As a pharmacist, I gained experience as a preceptor and as a PharmD student, once again I am the student myself.

I am writing from a unique point of view. A collection of experiences has led me to realize the features I appreciate in a preceptor and a student (upcoming part 2). My first letter… Dear Pharmacy...Read more

Guest post by:

Mark Pasetka B.Sc., B.Sc.Pharm., Pharm.D.

Clinical Pharmacy Coordinator

Odette Cancer Centre – Sunnybrook Health Sciences Centre

CAPhO President-Elect

Author's Note: "This was a radiation therapy focused article – i.e., that was limited to 1000 words and therefore, short. I focused on the 5-FU induced cardiotoxicity mostly and provided a very basic overview, not on anthracycline induced cardiotoxicity as is much more commonly reported."

Chemotherapy used for the treatment of cancer carry several significant...Read more

Blog tags: 

The following is the handout from my session at #ISOPP14 on social media:

Read more

Blog tags: 

Are you attending ISOPP 2014 in Montreal? Are you holding down the fort at your home site and unable to attend?

Well, either way you can follow along live with the following Twitter feed. For those unable to attend, feel like you are virtually there and feel free to add to the conversation. Tweet in touch, using #ISOPP14 hashtag:

(Note: you can scroll down through all the tweets below)

Read more

MASCC 2013 - Report from Nikki Ryan

The following is Nikki's report from our 2013 fall eNewsletter. Following that, please see the presentation she gave to staff at the Tom Baker Cancer Centre in Calgary, AB.

This past June I was given the opportunity to travel to the annual MASCC/ISOO symposium that was held in Berlin, Germany. This conference delivered top-notch education and covered a vast collection of topics...Read more

Blog tags: 

by Amy Smith (as part of her...Read more

Blog tags: 

by Amy Smith (as part of her Green Oncology series ) The Issue:

Complex patient issues require us to dig into...Read more

In case you missed it, CAPhO's Tom MacFarlane was tweeting live from ASH 2013 (#ASH13). ASH '13 is the American Society of Hematology's 2013 meeting, taking place in New Orleans, LA (#NOLA). In what was nothing short of an amazing effort, Tom, using CAPhO's Twitter account, placed us 9th out of over...Read more

by Amy Smith (as part of her Green Oncology series )

Working in oncology, we all have some desire to continuously learn. If we didn’t, we would quickly fall behind in practice, as oncology is a forever changing world. I too enjoy learning and being a student even if it means late nights studying and a significant portion of my income being donated to Starbucks .

This fall, I began the...Read more

We are pleased to announce CAPhO's own Tom MacFarlane plans to tweet live from ASH 2013 (#ASH13). ASH '13 is the American Society of Hematology's 2013 meeting, taking place in New Orleans, LA (#NOLA).

You can follow the @CAPhO_ACPh O (click on link) twitter account for all of his tweets or simply check in to see this live updated blog which will auto-update.


The Twitter hashtag to search for on Twitter to capture all of Tom's tweets (and to retweet!) is:...Read more

We hope all participants had a safe journey back to their respective destinations after an outstanding NOPS. The NOPS planning committee made the final official NOPS one to remember and the CAPhO Conference will carry on the tradition and continue to build upon all the momentum gained over the years.

Take a glance back at some of the great highlights from this past weekend's conference from the perspective of our social media all-stars. This is our #NOP2013 tweetcap (Twitter recap) - scroll down through and you can click "load more" to...Read more

Guest post by Melanie Danilak, BSc. Pharm, ACP (Pharmacy Clinical Educator, Cross Cancer Institute, Alberta Health Services)

By now we have all been approached by our patients who are confused about what they have heard on the news or read in the local paper: should I be taking tamoxifen for longer than 5 years? Results of the ATLAS (Adjuvant Tamoxifen: Longer Against Shorter) trial 1 , presented at SABCS 2012 and published in Lancet in March, 2013 had many of us re-thinking our usual "stop after 5 years" advice regarding adjuvant tamoxifen duration. The presentation of...Read more

by Amy Smith (as part of her ...Read more

by Amy Smith (as part of her Green Oncology series )

The Cost of Caring

(Photo: cover...Read more